Literature DB >> 22506502

Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii.

Anastasia V Popova1, Evgeny L Zhilenkov, Vera P Myakinina, Valentina M Krasilnikova, Nikolay V Volozhantsev.   

Abstract

Acinetobacter baumannii plays a significant role in infecting patients admitted to hospitals. Many A. baumannii infections, including ventilation-associated pneumonia, wound, and bloodstream infections, are common for intensive care and burn units. The ability of the microorganism to acquire resistance to many antibiotics, disinfectants, and dehydration assures its long-term survival in hospital settings. The application of bacteriophages is a potential tool to control A. baumannii infections. Bacteriophage AP22 lytic for A. baumannii was isolated from clinical materials and classified as a member of the Myoviridae family. The phage had an icosahedral head of 64 nm in diameter and a contractile tail of 85-90 nm in length. According to restriction analysis, AP22 had 46-kb double-stranded DNA genome. The phage AP22 exhibited rapid adsorption (> 99% adsorbed in 5 min), a large burst size (240 PFU per cell), and stability to the wide range of pH. The bacteriophage was shown to specifically infect and lyse 68% (89 of 130) genotype-varying multidrug-resistant clinical A. baumannii strains by forming clear zones. Thus, it could be used as a candidate for making up phage cocktails to control A. baumannii-associated nosocomial infections.
© 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22506502     DOI: 10.1111/j.1574-6968.2012.02573.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  23 in total

1.  Developing a bacteriophage cocktail for biocontrol of potato bacterial wilt.

Authors:  Cuihua Wei; Junli Liu; Alice Nyambura Maina; Francis B Mwaura; Junping Yu; Chenghui Yan; Ruofang Zhang; Hongping Wei
Journal:  Virol Sin       Date:  2017-11-16       Impact factor: 4.327

2.  Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii.

Authors:  Mya Thandar; Rolf Lood; Benjamin Y Winer; Douglas R Deutsch; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Characterization and Detection of Endolysin Gene from Three Acinetobacter baumannii Bacteriophages Isolated from Sewage Water.

Authors:  Thawatchai Kitti; Rapee Thummeepak; Aunchalee Thanwisai; Kamala Boonyodying; Duangkamol Kunthalert; Pannika Ritvirool; Sutthirat Sitthisak
Journal:  Indian J Microbiol       Date:  2014-05-21       Impact factor: 2.461

4.  Comparative genomic analysis of dwarf Vibrio myoviruses defines a conserved gene cluster for successful phage infection.

Authors:  Dimitrios Skliros; Efthymios Karpouzis; Chrysanthi Kalloniati; Pantelis Katharios; Emmanouil Flemetakis
Journal:  Arch Virol       Date:  2022-01-08       Impact factor: 2.574

5.  Isolation and Characterization of a Novel Siphoviridae Phage, vB_AbaS_TCUP2199, Infecting Multidrug-Resistant Acinetobacter baumannii.

Authors:  Meity Mardiana; Soon-Hian Teh; Ling-Chun Lin; Nien-Tsung Lin
Journal:  Viruses       Date:  2022-06-07       Impact factor: 5.818

6.  In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.

Authors:  Jongsoo Jeon; Choong-Min Ryu; Jun-Young Lee; Jong-Hwan Park; Dongeun Yong; Kyungwon Lee
Journal:  Appl Environ Microbiol       Date:  2016-06-30       Impact factor: 4.792

7.  Complete genome sequence of bacteriophage phiAC-1 infecting Acinetobacter soli strain KZ-1.

Authors:  Ji Hyung Kim; Chulhong Oh; Casiano H Choresca; Sang Phil Shin; Jee Eun Han; Jin Woo Jun; Soo-Jin Heo; Do-Hyung Kang; Se Chang Park
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

8.  Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii.

Authors:  Maia Merabishvili; Dieter Vandenheuvel; Andrew M Kropinski; Jan Mast; Daniel De Vos; Gilbert Verbeken; Jean-Paul Noben; Rob Lavigne; Mario Vaneechoutte; Jean-Paul Pirnay
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

9.  Atomic force microscopy analysis of the Acinetobacter baumannii bacteriophage AP22 lytic cycle.

Authors:  Evgeniy V Dubrovin; Anastasia V Popova; Sergey V Kraevskiy; Sergei G Ignatov; Tatyana E Ignatyuk; Igor V Yaminsky; Nikolay V Volozhantsev
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

10.  Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates.

Authors:  Fan Peng; Zhiqiang Mi; Yong Huang; Xin Yuan; Wenkai Niu; Yahui Wang; Yuhui Hua; Huahao Fan; Changqing Bai; Yigang Tong
Journal:  BMC Microbiol       Date:  2014-07-05       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.